Frailty as a predictor of disabilities among community-dwelling older people: a systematic review and meta-analysis.
read more
Citations
Frailty: implications for clinical practice and public health.
Frailty index as a predictor of mortality: a systematic review and meta-analysis
Global Incidence of Frailty and Prefrailty Among Community-Dwelling Older Adults: A Systematic Review and Meta-analysis.
Prevalence of frailty in Japan: A systematic review and meta-analysis.
Frailty syndrome: implications and challenges for health care policy.
References
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
Measuring inconsistency in meta-analyses
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Meta-analysis of observational studies in epidemiology - A proposal for reporting
The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses
Related Papers (5)
Frailty Consensus: A Call to Action
Frequently Asked Questions (15)
Q2. What are the future works mentioned in the paper "Frailty as a predictor of disabilities among community-dwelling older people: a systematic review and meta-analysis" ?
40,41 However, the findings of these studies are in line with the current meta-analysis and support frailty as a predictor of future disability risks. 40,41 Most of the included studies provided risk estimates adjusted for potential confounders, at least age and gender ( age only in male-only or female-only cohorts ), except for two studies16,26 which provided only unadjusted estimates. As included in the criteria of the Newcastle-Ottawa scale, it is important to control for the potential confounding factors to examine independent associations between frailty and disability. Although none of these group differences were statistically significant, these findings may suggest that the elderly with disability are more likely to develop more disabilities compared with those without.
Q3. How many studies were excluded from the review?
Of a total of 7,015 studies, 2,892 duplicate studies were excluded and 4,085 studies were excluded because the titles or abstracts were considered as not relevant, leaving 38 studies for full-text review.
Q4. What was the criteria used for the meta-analysis?
Studies potentially eligible for meta-analysis selected through systematic review of title, abstract, and full-text were examined for methodological quality using the Newcastle-Ottawa scale for cohort studies.
Q5. What was the method for comparing the risk estimates of different studies?
When two or more studies presented the same disability risk (incident ADL, worsening ADL, combined ADL, incident IADL, worsening IADL, or combined IADL) using the same type of risk estimates (OR or HR), the risk measures were combined to synthesize pooled estimates using the generic inverse variance method.
Q6. How many studies were excluded from the systematic review?
Of these, 18 studies were excluded because nine studies did not provide OR or HR of disability risk for frailty status, three studies did not used ADL or IADL to measure disability, two studies had cohorts with mean age of less than 60 years, two studies used the same cohorts, and twofor methodological quality using the Newcastle-Ottawa scale for cohort studies.
Q7. What was the significance of the random-effects model?
Random-effects models were used since significant heterogeneity was expected given different methodology and various frailty and disability definitions used across the included studies.
Q8. What was the purpose of the systematic review?
A systematic review of the literature was conducted by one researcher based on a protocol developed in accordance with Preferred Reporting Items for Systematic Review and MetaAnalyses (PRISMA)19 and Meta-analysis of Observational Studies in Epidemiology (MOOSE)20 statements using five electronic databases (Embase, MEDLINE, CINAHL Plus, PsycINFO, and the Cochrane Library) in September 2015.
Q9. What is the significance of the pooled HR?
Prefrailty was also shown to be a significant predictor of incident, worsening, and combined ADL disability95%CI=1.08-3.90, p=0.01, and 4 studies: pooled HR=1.58, 95%CI=1.24-2.02, p=0.01, respectively).
Q10. What is the significance of the pooled HR of incident IADL disability?
While a pooled HR of incident IADL disability for prefrailty did not reach statistical significance (3 studies15,24,28: pooled HR=1.35, 95%CI=0.86-2.10, p=0.19), prefrailty was significantly associated with worsening and combined IADL disability risks (3 studies28,35,36: pooled HR=1.92, 95%CI=1.19-3.09, p=0.007, and 5 studies15,24,28,35,36: pooled HR=1.55, 95%CI=1.08-2.21, p<0.00001, respectively).
Q11. What criteria were used to classify those who were classified as frail?
Those who were classified as frail had roughly two-fold or higher risks of incident, worsening, and combined ADL and IADL disability using OR and HR compared with thoseto a lesser degree.
Q12. What databases were used to perform the analysis?
All analysis were performed using Review Manager 5 (version 5.2, The Cochrane Collaboration, Copenhagen, Denmark), IBM SPSS Statistics (version 22, IBM Corporation, New York, USA), and StatsDirect (version 2.8, StatsDirect, Cheshire, UK).
Q13. How many studies were identified from the five databases?
The initial literature search using the five databases yielded 7,012 studies and 3 additional studies were identified from reference lists of relevant articles.
Q14. What is the first systematic review and meta-analysis of frailty?
(Figure 3 A-F)This systematic review and meta-analysis provides the first pooled evidence that frailty is a significant predictor of ADL and IADL disability among community-dwelling older people.
Q15. What was the significance of the association between frailty and disability?
24The meta-analysis of the associations between frailty and ADL disability included 12 studies with OR15-17,24-29,31,37,38 and five studies with HR.2,23,30,32,34 Both frailty and prefrailty were significant predictors of ADL disability (incident, worsening, and combined) persistently in all meta-analysis.